I
Immuneel Therapeutics develops affordable CAR-T cell therapies for blood cancers including lymphoma and leukemia.
$1Series B
Immuneel Therapeutics develops affordable CAR-T cell therapies for blood cancers including lymphoma and leukemia.
Immuneel Therapeutics develops affordable CAR-T cell therapies for blood cancers including lymphoma and leukemia.
Want a deeper look at Immuneel Therapeutics?
Ask Dormy who's likely on their cap table, what kind of companies their lead investor backs, and how to reach them.